| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/08/2023 | 235.77% | Wedbush | → $23 | Reiterates | Outperform → Outperform |
| 10/18/2023 | 235.77% | JMP Securities | → $23 | Initiates Coverage On | → Market Outperform |
| 09/14/2023 | 250.36% | HC Wainwright & Co. | → $24 | Reiterates | Buy → Buy |
| 08/09/2023 | 250.36% | HC Wainwright & Co. | → $24 | Reiterates | Buy → Buy |
| 04/03/2023 | 235.77% | Wedbush | → $23 | Reiterates | → Outperform |
| 03/31/2023 | 118.98% | Mizuho | → $15 | Initiates Coverage On | → Buy |
| 03/27/2023 | 89.78% | Morgan Stanley | $12 → $13 | Maintains | Equal-Weight |
| 03/22/2023 | 250.36% | HC Wainwright & Co. | → $24 | Reiterates | → Buy |
| 11/14/2022 | 75.18% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 11/11/2022 | 177.37% | Guggenheim | $22 → $19 | Maintains | Buy |
| 09/16/2022 | 177.37% | Wedbush | → $19 | Initiates Coverage On | → Outperform |
| 08/29/2022 | 250.36% | HC Wainwright & Co. | → $24 | Initiates Coverage On | → Buy |
| 05/17/2022 | 60.58% | Morgan Stanley | $17 → $11 | Maintains | Equal-Weight |
| 02/01/2022 | 250.36% | Stifel | → $24 | Initiates Coverage On | → Buy |
| 02/01/2022 | 148.18% | Morgan Stanley | → $17 | Initiates Coverage On | → Equal-Weight |
| 02/01/2022 | 191.97% | Jefferies | → $20 | Initiates Coverage On | → Buy |
What is the target price for Vigil Neuroscience (VIGL)?
The latest price target for Vigil Neuroscience (NASDAQ: VIGL) was reported by Wedbush on November 8, 2023. The analyst firm set a price target for $23.00 expecting VIGL to rise to within 12 months (a possible 235.77% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vigil Neuroscience (VIGL)?
The latest analyst rating for Vigil Neuroscience (NASDAQ: VIGL) was provided by Wedbush, and Vigil Neuroscience reiterated their outperform rating.
When is the next analyst rating going to be posted or updated for Vigil Neuroscience (VIGL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vigil Neuroscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vigil Neuroscience was filed on November 8, 2023 so you should expect the next rating to be made available sometime around November 8, 2024.
Is the Analyst Rating Vigil Neuroscience (VIGL) correct?
While ratings are subjective and will change, the latest Vigil Neuroscience (VIGL) rating was a reiterated with a price target of $0.00 to $23.00. The current price Vigil Neuroscience (VIGL) is trading at is $6.85, which is within the analyst's predicted range.